Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 49, Issue 3 (Mar 2011)

Issues

The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?

Martina Montagnana
  • Clinical Biochemistry Laboratory, Department of Life and Reproduction Sciences, University Hospital of Verona, Verona, Italy
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Elisa Danese
  • Clinical Biochemistry Laboratory, Department of Life and Reproduction Sciences, University Hospital of Verona, Verona, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Orazio Ruzzenente
  • Clinical Biochemistry Laboratory, Department of Life and Reproduction Sciences, University Hospital of Verona, Verona, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Valentina Bresciani
  • Obstetrics and Gynecology Clinics, Department of Life and Reproduction Sciences, University Hospital of Verona, Verona, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Teresita Nuzzo
  • Obstetrics and Gynecology Clinics, Department of Life and Reproduction Sciences, University Hospital of Verona, Verona, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Matteo Gelati
  • Clinical Biochemistry Laboratory, Department of Life and Reproduction Sciences, University Hospital of Verona, Verona, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Gian Luca Salvagno
  • Clinical Biochemistry Laboratory, Department of Life and Reproduction Sciences, University Hospital of Verona, Verona, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Massimo Franchi
  • Obstetrics and Gynecology Clinics, Department of Life and Reproduction Sciences, University Hospital of Verona, Verona, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Giuseppe Lippi
  • Clinical Chemistry and Hematology Laboratory, Department of Pathology and Laboratory Medicine, University Hospital of Parma, Parma, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Gian Cesare Guidi
  • Clinical Biochemistry Laboratory, Department of Life and Reproduction Sciences, University Hospital of Verona, Verona, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2011-02-03 | DOI: https://doi.org/10.1515/CCLM.2011.075

Abstract

Background: The study is aimed at evaluating the performance of the predictive model ROMA (Risk of Ovarian Malignancy Algorithm), which utilizes the combination of human epididymis protein 4 (HE4) and CA125 values to assess the risk of epithelial ovarian cancer (EOC) in women with a pelvic mass.

Methods: One hundred and four women diagnosed with a pelvic mass (55 EOC and 49 benign cases) and scheduled to have surgery were enrolled, along with 49 healthy females. Preoperative serum concentrations of HE4 and CA125 were measured. Separate logistic regression algorithms ROMA for pre-menopausal and post-menopausal women were used to categorize patients into low- and high-risk groups for EOC. The area under the curve (AUC), sensitivity and specificity were calculated for HE4, CA125 and ROMA for the diagnosis of ovarian cancer using receiver operating characteristic (ROC) analysis.

Results: The median CA125 and HE4 serum concentrations were significantly higher among EOC patients than in healthy females (both p<0.05) and those with a benign mass (both p<0.05). The pre-menopausal group included 36 benign cases (29 of which were classified by ROMA as low-risk with a specificity of 80.6%; 95% CI: 64.0%–91.8%), and 15 EOC (eight of which were classified by ROMA as high-risk, with a sensitivity of 53.3%; 95% CI: 26.6%–78.7%). The post-menopausal group enclosed 13 benign cases (11 of which were classified by ROMA as low-risk with a specificity of 84.6%; 95% CI: 54.6%–98.0%), and 40 EOC (33 of which were classified by ROMA as high-risk with a sensitivity of 82.5%; 95% CI: 67.2%–92.7%). In the pre-menopausal group, the AUC was 0.64 (p=0.12, 95% CI: 0.44–0.83) for CA125, 0.77 (p=0.003, 95% CI: 0.62–0.92) for HE4 and 0.77 (p=0.002, 95% CI: 0.63–0.92) for ROMA. In the post-menopausal group, the AUC was 0.84 (p=0.0003, 95% CI: 0.73–0.94) for CA125, 0.94 (p<0.0001, 95% CI: 0.88–0.99) for HE4 and 0.92 (p<0.0001, 95% CI: 0.85–0.99) for ROMA.

Conclusions: The ROMA is a simple scoring system which shows excellent diagnostic performance for the detection of EOC in post-menopausal women, but not in pre-menopausal women. Moreover, the dual marker combination of HE4 and CA125 (ROMA) does not show better performance than HE4 alone.

Keywords: biomarkers; CA125; epithelial ovarian cancer; human epididymis protein 4; pelvic mass

About the article

Corresponding author: Dr. Martina Montagnana, Sezione di Biochimica Clinica, Dipartimento di Scienze della Vita e della Riproduzione, Ospedale Policlinico G.B. Rossi, Piazzale Scuro 10, Verona 37134, Italy Phone: +39-045-8126698, Fax: +39-045-8027484


Received: 2010-08-06

Accepted: 2010-10-21

Published Online: 2011-02-03

Published in Print: 2011-03-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2011.075.

Export Citation

©2011 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Cheng-Chang Chang, Hui-Chen Wang, Yu-Ping Liao, Yu-Chih Chen, Yu-Chun Weng, Mu-Hsien Yu, and Hung-Cheng Lai
Journal of Gynecologic Oncology, 2018, Volume 29
[2]
Elisabeth Reiser, Stefanie Aust, Veronika Seebacher, Alexander Reinthaller, Samir Helmy-Bader, Richard Schwameis, Christoph Grimm, and Stephan Polterauer
Gynecologic Oncology, 2017
[3]
Giuseppe Scaletta, Francesco Plotti, Daniela Luvero, Stella Capriglione, Roberto Montera, Andrea Miranda, Salvatore Lopez, Corrado Terranova, Carlo De Cicco Nardone, and Roberto Angioli
Expert Review of Anticancer Therapy, 2017, Volume 17, Number 9, Page 827
[4]
Ignacio Zapardiel, Mikel Gorostidi, Antonella Ravaggi, Maria T. Allende, Margarida Silveira, and Ronalds Macuks
European Journal of Cancer Prevention, 2017, Volume 26, Number 4, Page 346
[5]
Wei-Lei Yang, Zhen Lu, and Robert C. Bast
Expert Review of Molecular Diagnostics, 2017, Volume 17, Number 6, Page 577
[6]
Richard G. Moore, Beth Plante, Erin Hartnett, Jessica Mitchel, Christine A. Raker, Wendy Vitek, Elizabeth Eklund, and Geralyn Lambert-Messerlian
American Journal of Obstetrics and Gynecology, 2017, Volume 217, Number 1, Page 53.e1
[7]
Giuliano Moysés Borrelli, Leandro Accardo de Mattos, Marina de Paula Andres, Manoel Orlando Gonçalves, Rosanne M. Kho, and Mauricio Simões Abrão
Journal of Minimally Invasive Gynecology, 2017, Volume 24, Number 3, Page 353
[8]
Martina Montagnana, Marco Benati, Elisa Danese, Silvia Giudici, Melissa Perfranceschi, Orazio Ruzzenenete, Gian Luca Salvagno, Antonella Bassi, Matteo Gelati, Elisa Paviati, Gian Cesare Guidi, Massimo Franchi, and Giuseppe Lippi
International Journal of Gynecological Cancer, 2017, Volume 27, Number 3, Page 459
[9]
Wanglei Qu, Quansheng Gao, Haibin Chen, Zuoqing Tang, Xueqiong Zhu, and Shi-Wen Jiang
Expert Review of Molecular Diagnostics, 2017, Volume 17, Number 3, Page 239
[10]
Mariya A Egunova and Irina G Kutsenko
Journal of obstetrics and woman disease, 2016, Volume 65, Number 6, Page 68
[11]
Maciej Stukan, Miroslaw Dudziak, Karol Ratajczak, and Jacek P. Grabowski
Journal of Ultrasound in Medicine, 2015, Volume 34, Number 2, Page 207
[12]
Inés P. Mariño, Oleg Blyuss, Andy Ryan, Aleksandra Gentry-Maharaj, John F. Timms, Anne Dawnay, Jatinderpal Kalsi, Ian Jacobs, Usha Menon, and Alexey Zaikin
Biomedical Signal Processing and Control, 2017, Volume 33, Page 169
[13]
Elham O Hamed, Hydi Ahmed, Osama B Sedeek, Abeer M Mohammed, Ali A Abd-Alla, and Hazem M Abdel Ghaffar
Diagnostic Pathology, 2013, Volume 8, Number 1
[14]
S. Bel, A. Gaudineau, V. Thoma, O. Garbin, N. Sananes, E. Baulon, M. Hummel, A. Wattiez, J.-J. Baldauf, and C. Akladios
EMC - Ginecología-Obstetricia, 2016, Volume 52, Number 4, Page 1
[15]
Wanglei Qu, Jinping Li, Ping Duan, Zuoqing Tang, Fengbiao Guo, Haibin Chen, Xueqiong Zhu, and Shi-Wen Jiang
Expert Review of Molecular Diagnostics, 2016, Volume 16, Number 12, Page 1271
[16]
Mesut Onal, Erdal Malatyalioglu, Emel Kurtoglu Ozdes, Handan Celik, Keramettin Yanik, Migraci Tosun, Fatma Devran Bildircin, Tayfun Alper, Mehmet Bilge Cetinkaya, and Arif Kokcu
Indian Journal of Gynecologic Oncology, 2016, Volume 14, Number 3
[17]
Fake Li, Ruxiu Tie, Kai Chang, Feng Wang, Shaoli Deng, Weiping Lu, Lili Yu, and Ming Chen
BMC Cancer, 2012, Volume 12, Number 1
[18]
Adriana Yoshida, Sophie Françoise Derchain, Denise Rocha Pitta, Liliana Aparecida Lucci De Angelo Andrade, and Luis Otavio Sarian
Gynecologic Oncology, 2016, Volume 140, Number 3, Page 481
[19]
Cesare Romagnolo, Antonette E. Leon, Aline S.C. Fabricio, Martina Taborelli, Jerry Polesel, Lino Del Pup, Agostino Steffan, Silvia Cervo, Antonella Ravaggi, Laura Zanotti, Elisabetta Bandiera, Franco E. Odicino, Novella Scattolo, Elisa Squarcina, Christine Papadakis, Tiziano Maggino, and Massimo Gion
Gynecologic Oncology, 2016, Volume 141, Number 2, Page 303
[20]
Anita Chudecka-Głaz, Aneta Cymbaluk-Płoska, Jolanta Jastrzębska, and Janusz Menkiszak
Tumor Biology, 2016, Volume 37, Number 7, Page 8879
[21]
Oleg Blyuss, Alex Gentry-Maharaj, Evangelia-Orania Fourkala, Andy Ryan, Alexey Zaikin, Usha Menon, Ian Jacobs, and John F. Timms
BioMed Research International, 2015, Volume 2015, Page 1
[23]
Giuseppe Cartei, Francesco Cartei, Martina Bertin, Andrea Padoan, Fable Zustovich, Maria Ornella Nicoletto, and Mario Plebani
Clinical Chemistry and Laboratory Medicine, 2013, Volume 51, Number 2
[24]
Alan Kirwan, Marta Utratna, Michael E. O’Dwyer, Lokesh Joshi, and Michelle Kilcoyne
BioMed Research International, 2015, Volume 2015, Page 1
[25]
Jiabin Chen, Chung Chang, Hung-Chi Huang, Yu-Che Chung, Huan-Jung Huang, Wen Shiung Liou, An Jen Chiang, and Nelson N.H. Teng
Taiwanese Journal of Obstetrics and Gynecology, 2015, Volume 54, Number 4, Page 398
[26]
Pengjun Zhang, Chuanxin Wang, Liming Cheng, Peng Zhang, Lin Guo, Wanli Liu, Zhongying Zhang, Yanchun Huang, Qishui Ou, Xinyu Wen, and Yaping Tian
Tumor Biology, 2016, Volume 37, Number 2, Page 2183
[27]
L.-T. Jia, Y.-C. Zhang, J. Li, Y. Tian, and J.-F. Li
Clinical and Translational Oncology, 2016, Volume 18, Number 3, Page 233
[28]
Anthony Richards, Unine Herbst, Jane Manalang, Selvan Pather, Samir Saidi, Trevor Tejada-Berges, Kris Tan, Paul Williams, and Jonathan Carter
Australian and New Zealand Journal of Obstetrics and Gynaecology, 2015, Volume 55, Number 5, Page 493
[29]
Mona A. Karlsen, Estrid V.S. Høgdall, Ib J. Christensen, Christer Borgfeldt, Grigorios Kalapotharakos, Lenka Zdrazilova-Dubska, Josef Chovanec, Christianne A.R. Lok, Anna Stiekema, Irene Mutz-Dehbalaie, Adam N. Rosenthal, Elizabeth K. Moore, Beth A. Schodin, Walfrido W. Sumpaico, Karin Sundfeldt, Björg Kristjansdottir, Ignacio Zapardiel, and Claus K. Høgdall
Gynecologic Oncology, 2015, Volume 138, Number 3, Page 640
[30]
Jian-Xiang Shi, Jie-Jie Qin, Hua Ye, Peng Wang, Kai-Juan Wang, and Jian-Ying Zhang
Expert Review of Molecular Diagnostics, 2015, Page 1
[31]
Teresa Granato, Maria Grazia Porpora, Flavia Longo, Antonio Angeloni, Lucia Manganaro, and Emanuela Anastasi
Clinica Chimica Acta, 2015, Volume 446, Page 147
[32]
Mohamed A. Elzek and Karin D. Rodland
Cancer and Metastasis Reviews, 2015, Volume 34, Number 1, Page 83
[33]
Anita Monika Chudecka-Głaz
Clinica Chimica Acta, 2015, Volume 440, Page 143
[34]
Richard G. Moore, Douglas M. Hawkins, M. Craig Miller, Lisa M. Landrum, Walter Gajewski, John J. Ball, W. Jeffery Allard, and Steven J. Skates
Gynecologic Oncology, 2014, Volume 135, Number 3, Page 547
[35]
Pei-long Li, Xin Zhang, Tong-fu Li, Li-li Wang, Lu-tao Du, Yong-mei Yang, Juan Li, Hai-yan Wang, Yi Zhang, and Chuan-xin Wang
Clinica Chimica Acta, 2015, Volume 439, Page 148
[36]
Sohiya Yotsukura and Hiroshi Mamitsuka
Critical Reviews in Oncology/Hematology, 2015, Volume 93, Number 2, Page 103
[37]
János Kappelmayer, Péter Antal-Szalmás, and Béla Nagy
Clinica Chimica Acta, 2015, Volume 438, Page 35
[38]
Farah Farzaneh, Zahra Honarvar, Mansoore Yaraghi, Mehdi Yaseri, Maliheh Arab, Maryamsadat Hosseini, and Tahereh Ashrafgangoi
Iranian Red Crescent Medical Journal, 2014, Volume 16, Number 6
[39]
Shi-Wen Jiang, Haibin Chen, Sean Dowdy, Alex Fu, John Attewell, Eleftheria Kalogera, Ronny Drapkin, Karl Podratz, Russell Broaddus, and Jinping Li
International Journal of Molecular Sciences, 2013, Volume 14, Number 11, Page 22655
[40]
Jiwen Wang, Jia Gao, Hongwen Yao, Zongyong Wu, Minjie Wang, and Jun Qi
Tumor Biology, 2014, Volume 35, Number 6, Page 6127
[41]
Richard G. Moore, Emily K. Hill, Timothy Horan, Naohiro Yano, KyuKwang Kim, Shannon MacLaughlan, Geralyn Lambert-Messerlian, YiTang Don Tseng, James F. Padbury, M. Craig Miller, Thilo S. Lange, and Rakesh K. Singh
Scientific Reports, 2015, Volume 4, Number 1
[42]
J. Kaijser, T. Van Gorp, M.-E. Smet, C. Van Holsbeke, A. Sayasneh, E. Epstein, T. Bourne, I. Vergote, B. Van Calster, and D. Timmerman
Ultrasound in Obstetrics & Gynecology, 2014, Volume 43, Number 1, Page 89
[43]
J. Kaijser, A. Sayasneh, K. Van Hoorde, S. Ghaem-Maghami, T. Bourne, D. Timmerman, and B. Van Calster
Human Reproduction Update, 2014, Volume 20, Number 3, Page 449
[44]
N. Lahlou and J.-L. Brun
Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2013, Volume 42, Number 8, Page 752
[45]
Jingjing Yang, Mu Sa, Meng Huang, Jiajin Yang, Zhongyuan Xiang, Bo Liu, and Aiguo Tang
Clinical Biochemistry, 2013, Volume 46, Number 16-17, Page 1705
[46]
Karina Biskup, Elena I. Braicu, Jalid Sehouli, Christina Fotopoulou, Rudolf Tauber, Markus Berger, and Véronique Blanchard
Journal of Proteome Research, 2013, Volume 12, Number 9, Page 4056
[47]
Shin Hye Chung, Soo Yoon Lee, Woong Ju, and Seung Cheol Kim
Obstetrics & Gynecology Science, 2013, Volume 56, Number 4, Page 234
[48]
Brian M. Nolen and Anna E. Lokshin
Molecular Diagnosis & Therapy, 2013, Volume 17, Number 3, Page 139
[49]
Gina Brown
Journal of the American Academy of Physician Assistants, 2012, Volume 25, Number 8, Page 46
[50]
Srinivas Kondalsamy-Chennakesavan, Andreas Hackethal, David Bowtell, and Andreas Obermair
Gynecologic Oncology, 2013, Volume 129, Number 3, Page 467
[51]
Jeroen Kaijser, Toon Van Gorp, Kirsten Van Hoorde, Caroline Van Holsbeke, Ahmad Sayasneh, Ignace Vergote, Tom Bourne, Dirk Timmerman, and Ben Van Calster
Gynecologic Oncology, 2013, Volume 129, Number 2, Page 377
[52]
J. Kaijser, T. Bourne, L. Valentin, A. Sayasneh, C. Van Holsbeke, I. Vergote, A. C. Testa, D. Franchi, B. Van Calster, and D. Timmerman
Ultrasound in Obstetrics & Gynecology, 2013, Volume 41, Number 1, Page 9
[53]
Robert E. Bristow, Alan Smith, Zhen Zhang, Daniel W. Chan, Gillian Crutcher, Eric T. Fung, and Donald G. Munroe
Gynecologic Oncology, 2013, Volume 128, Number 2, Page 252
[54]
Mona Aarenstrup Karlsen, Noreen Sandhu, Claus Høgdall, Ib Jarle Christensen, Lotte Nedergaard, Lene Lundvall, Svend A. Engelholm, Anette T. Pedersen, Dorthe Hartwell, Magnus Lydolph, Inga Alice Laursen, and Estrid V.S. Høgdall
Gynecologic Oncology, 2012, Volume 127, Number 2, Page 379
[55]
Jason E. Dodge, Allan L. Covens, Christina Lacchetti, Laurie M. Elit, Tien Le, Michaela Devries-Aboud, and Michael Fung-Kee-Fung
Gynecologic Oncology, 2012, Volume 126, Number 1, Page 157
[56]
Brian M Nolen and Anna E Lokshin
Expert Opinion on Medical Diagnostics, 2012, Volume 6, Number 2, Page 131
[58]
Richard G. Moore, Michael Craig Miller, Margaret M. Steinhoff, Steven J. Skates, Karen H. Lu, Geralyn Lambert-Messerlian, and Robert C. Bast
American Journal of Obstetrics and Gynecology, 2012, Volume 206, Number 4, Page 351.e1
[59]
Sasa Kadija, Aleksandar Stefanovic, Katarina Jeremic, Milos M. Radojevic, Ljubinka Nikolic, Ivanka Markovic, and Jasmina Atanackovic
International Journal of Gynecological Cancer, 2012, Volume 22, Number 2, Page 238
[60]
Nils Bolstad, Miriam Øijordsbakken, Kjell Nustad, and Johan Bjerner
Tumor Biology, 2012, Volume 33, Number 1, Page 141
[61]
Bohuslav Melichar and Mario Plebani
Clinical Chemistry and Laboratory Medicine, 2012, Volume 50, Number 3
[62]
Rafael Molina, Jose M. Escudero, Jose M. Augé, Xavier Filella, Laura Foj, Aureli Torné, Jose Lejarcegui, and Jaume Pahisa
Tumor Biology, 2011, Volume 32, Number 6, Page 1087
[63]
Bohuslav Melichar and Mario Plebani
Clinical Chemistry and Laboratory Medicine, 2012, Volume 50, Number 1, Page 1
[64]
Giuseppina Ruggeri, Elisabetta Bandiera, Laura Zanotti, Silvana Belloli, Antonella Ravaggi, Chiara Romani, Eliana Bignotti, Renata A. Tassi, Germana Tognon, Claudio Galli, Luigi Caimi, and Sergio Pecorelli
Clinica Chimica Acta, 2011, Volume 412, Number 15-16, Page 1447
[65]
Richard G. Moore, M. Craig Miller, Paul Disilvestro, Lisa M. Landrum, Walter Gajewski, John J. Ball, and Steven J. Skates
Obstetrics & Gynecology, 2011, Volume 118, Number 2, Part 1, Page 280
[66]
Mario Plebani and Bohuslav Melichar
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 3

Comments (0)

Please log in or register to comment.
Log in